Skip to main content
. 2017 Aug 7;8(53):91150–91161. doi: 10.18632/oncotarget.20017

Table 8. Adverse events after CCRT in the two arms.

Adverse events TPF arm TP arm Z p
0 1 2 3 4 0 1 2 3 4
Hematologic
Leukocytopenia 15 20 18 4 0 16 30 17 12 0 –0.676 0.499
Neutropenia 14 14 19 8 2 24 29 12 7 3 –1.839 0.066
Anemia 43 10 4 0 0 51 18 6 0 0 –0.886 0.375
Thrombocytopenia 42 6 6 3 0 61 5 6 2 1 –1.000 0.371
Liver function 46 10 1 0 0 69 6 0 0 0 –1.935 0.053
Renal function 56 1 0 0 0 75 0 0 0 0 –1.147 0.251
Non-hematologic
Mucositis 0 26 28 3 0 0 35 36 4 0 –0.106 0.915
Dermatitis 0 53 3 1 0 0 70 5 0 0 –0.105 0.916
Diarrhea 51 3 2 1 0 70 3 2 0 0 –0.815 0.415
Nausea/vomiting 49 7 1 0 0 64 6 4 1 0 –0.215 0.830

Abbreviations: CCRT, concurrent chemoradiotherapy.